Skip to main content
S 621 113th Congress Senate Crime and Law Enforcement Drug trafficking and controlled substances Health care coverage and access Long-term, rehabilitative, and terminal care Prescription drugs Rural conditions and development

Safe Prescribing Act of 2013

Introduced: March 20, 2013 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 20, 2013
Read twice and referred to the Committee on the Judiciary.
Mar 20, 2013
Introduced in Senate
 Plain-English summary Congressional Research Service

Safe Prescribing Act of 2013 - Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance.

Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone combination products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date of enactment of this Act.

Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

What's happening now March 20, 2013

Read twice and referred to the Committee on the Judiciary.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 3